Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.

DNAC

Social Capital Suvretta ... (DNAC)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:DNAC
DataOraFonteTitoloSimboloCompagnia
16/06/202322:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
26/05/202314:01Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
26/05/202313:33Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
11/05/202322:11Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
21/04/202312:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
17/04/202323:02Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
04/04/202322:47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
29/03/202312:06Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
28/03/202322:47Edgar (US Regulatory)Annual Report (10-k)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
14/02/202318:24Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
06/01/202322:59Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
26/08/202222:07Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
12/08/202213:16Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
09/08/202212:10Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
22/07/202222:40Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
22/07/202212:01Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
20/07/202222:32Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
12/07/202214:00GlobeNewswire Inc.Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq Following Business Combination with Social Capital Suvretta Holdings Corp. IIINASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
09/07/202201:36Business WireSocial Capital Suvretta Holdings Corp. III Announces Reconvened Extraordinary General Meeting of ShareholdersNASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
06/07/202214:46Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
23/06/202214:00GlobeNewswire Inc.ProKidney Corroborates the Mechanism of Action of REACT™ with Cell Marker Analysis in Patients with Diabetic Chronic Kidney DiseaseNASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
15/06/202214:00GlobeNewswire Inc.ProKidney Announces Manufacturing Efficiency Initiatives and Supply Chain Streamlining Expected to Reduce REACT™ Manufacturing CostsNASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
10/06/202222:55Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
07/06/202214:00GlobeNewswire Inc.Observed Safety Profile Supports Bilateral Dosing of ProKidney’s REACT™ – 007 UpdateNASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
20/05/202215:00GlobeNewswire Inc.ProKidney to present at upcoming investor conferencesNASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
06/05/202222:48Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
03/05/202214:00GlobeNewswire Inc.ProKidney highlights key registrational program elements supporting advancement of REACT®NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
18/04/202215:30GlobeNewswire Inc.ProKidney and Social Capital Suvretta Holdings Corp. III (“SCS”) to Host Analyst and Investor Day on April 28, 2022NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
12/04/202214:00GlobeNewswire Inc.ProKidney confirms Phase 3 program for autologous kidney cell therapy REACT®NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
14/02/202223:14Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (preliminary) (prem14a)NASDAQ:DNACSocial Capital Suvretta Holdings Corporation III
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:DNAC
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network